Skip to main content
. 2017 Aug 23;174(19):3346–3358. doi: 10.1111/bph.13953

Figure 1.

Figure 1

Study design. Mice were treated with 3 mg·kg−1 of montelukast (MK) prepared in a 1% MC solution. Control mice received 1% MC alone. montelukast or MC was administered in a volume of 200 μL using a 22 gauge gavage needle. Mice were treated three times: 24 h prior to chlorine (Cl2) exposure, 1 h prior to chlorine exposure and 1 h prior to evaluation of AHR.